Matches in Wikidata for { <http://www.wikidata.org/entity/Q83294099> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- Q83294099 description "article scientifique publié en 2006" @default.
- Q83294099 description "artículu científicu espublizáu en mayu de 2006" @default.
- Q83294099 description "im Mai 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q83294099 description "scientific article published on 03 May 2006" @default.
- Q83294099 description "wetenschappelijk artikel" @default.
- Q83294099 description "наукова стаття, опублікована в травні 2006" @default.
- Q83294099 name "CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan" @default.
- Q83294099 name "CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan" @default.
- Q83294099 type Item @default.
- Q83294099 label "CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan" @default.
- Q83294099 label "CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan" @default.
- Q83294099 prefLabel "CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan" @default.
- Q83294099 prefLabel "CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan" @default.
- Q83294099 P1433 Q83294099-78164B33-8B4E-46F6-A4F9-D9E90F5528C6 @default.
- Q83294099 P1476 Q83294099-7AA15B5D-3554-4F19-BB82-A75054D681E4 @default.
- Q83294099 P2093 Q83294099-36DDACAD-0795-4D5E-BAF3-FF79DC5D3ECC @default.
- Q83294099 P2093 Q83294099-6AAB2573-9D46-4864-B5CD-1874E3457AE1 @default.
- Q83294099 P2093 Q83294099-6F9F3FB7-FEF0-4F6A-BEA5-69B62FA8E0DA @default.
- Q83294099 P2093 Q83294099-6FB44978-7695-4537-A15F-8A68564B2D76 @default.
- Q83294099 P2093 Q83294099-720FCDC3-EE61-405A-996C-416F22543C8E @default.
- Q83294099 P2093 Q83294099-7B76631D-3F61-4A9C-BCEC-6D5CC6D8925E @default.
- Q83294099 P2093 Q83294099-93413783-AF89-43FE-BBE7-52E709F821CD @default.
- Q83294099 P2093 Q83294099-DA2A8590-EBBE-4816-ADE8-3F7AB0CF548B @default.
- Q83294099 P2860 Q83294099-06B51128-50DD-4087-A8EE-16D8BFDD3144 @default.
- Q83294099 P2860 Q83294099-1CA8A20D-53B7-443D-8978-5C43125885C1 @default.
- Q83294099 P2860 Q83294099-290F233F-B26D-4E1A-8283-C810A691A085 @default.
- Q83294099 P2860 Q83294099-48B3EDA9-EE4B-47AF-A2CB-F5BB4238ACDC @default.
- Q83294099 P2860 Q83294099-53C79F60-0D9D-417A-9370-BB420E964831 @default.
- Q83294099 P2860 Q83294099-581CD82E-6EAE-44D7-AF88-57DD31B73D53 @default.
- Q83294099 P2860 Q83294099-6509A587-4F13-4B8D-8609-9F0D9FF66D39 @default.
- Q83294099 P2860 Q83294099-71BC49E8-6803-4711-9CB6-A1C25C89A24A @default.
- Q83294099 P2860 Q83294099-921DE5CF-4A0B-4D34-AA6C-34679DF5E327 @default.
- Q83294099 P2860 Q83294099-ACBEC4BD-F962-4820-934B-79899737CB3D @default.
- Q83294099 P2860 Q83294099-AD121BA5-1B19-4C6E-8F42-530D128BC2F3 @default.
- Q83294099 P2860 Q83294099-B2066D6C-5541-4250-AB5E-C50E97F785B1 @default.
- Q83294099 P2860 Q83294099-D1ABDE6F-0D53-4461-BC9E-0FF9D861BD71 @default.
- Q83294099 P2860 Q83294099-E36378E1-A0CF-4FFA-90E2-F12F79BFDA33 @default.
- Q83294099 P2860 Q83294099-E43EA5C7-0B8A-4CFD-8ACA-755178AD83EA @default.
- Q83294099 P2860 Q83294099-ECC47BDD-5E98-4740-9291-CDDD94D964CE @default.
- Q83294099 P2860 Q83294099-EF46F7CA-C2A0-4EBB-9720-18F5C1C959E6 @default.
- Q83294099 P2860 Q83294099-F00CFD80-3368-4EE1-937E-1A2A8A0F88BD @default.
- Q83294099 P2860 Q83294099-F751D1E1-8588-423E-B4F1-81E5CBC23CF4 @default.
- Q83294099 P304 Q83294099-94F6C452-C040-42F7-813C-E028FB846161 @default.
- Q83294099 P31 Q83294099-245FC620-D0E2-4ED0-813B-B9D33ABAB959 @default.
- Q83294099 P356 Q83294099-83752A24-28C6-4E7D-ABCF-3FAB7E6B26F3 @default.
- Q83294099 P433 Q83294099-13FEEB24-E87A-47F1-8A84-2CC0D1A82095 @default.
- Q83294099 P478 Q83294099-01D15C34-041C-4D25-ADEF-BF286ED09082 @default.
- Q83294099 P577 Q83294099-9CD9C41D-0577-4077-8E4F-DF2D97585EC4 @default.
- Q83294099 P698 Q83294099-C13AD2FF-96F5-461A-9826-D1CD8D70F9E8 @default.
- Q83294099 P921 Q83294099-CFE97F45-28C8-483C-B707-108CFDF76971 @default.
- Q83294099 P356 J.YGYNO.2006.02.026 @default.
- Q83294099 P698 16677696 @default.
- Q83294099 P1433 Q5625182 @default.
- Q83294099 P1476 "CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan" @default.
- Q83294099 P2093 "David G Mutch" @default.
- Q83294099 P2093 "Gabrielle Gossner" @default.
- Q83294099 P2093 "Janet S Rader" @default.
- Q83294099 P2093 "Matthew A Powell" @default.
- Q83294099 P2093 "Neil S Horowitz" @default.
- Q83294099 P2093 "Randall K Gibb" @default.
- Q83294099 P2093 "Robert L Coleman" @default.
- Q83294099 P2093 "Thomas J Herzog" @default.
- Q83294099 P2860 Q27860904 @default.
- Q83294099 P2860 Q29617572 @default.
- Q83294099 P2860 Q33337137 @default.
- Q83294099 P2860 Q33750008 @default.
- Q83294099 P2860 Q34254918 @default.
- Q83294099 P2860 Q34582661 @default.
- Q83294099 P2860 Q35125943 @default.
- Q83294099 P2860 Q35789906 @default.
- Q83294099 P2860 Q40471819 @default.
- Q83294099 P2860 Q40669502 @default.
- Q83294099 P2860 Q45057186 @default.
- Q83294099 P2860 Q45976411 @default.
- Q83294099 P2860 Q54039002 @default.
- Q83294099 P2860 Q54061091 @default.
- Q83294099 P2860 Q57618520 @default.
- Q83294099 P2860 Q67989907 @default.
- Q83294099 P2860 Q71059798 @default.
- Q83294099 P2860 Q71528582 @default.
- Q83294099 P2860 Q73443071 @default.
- Q83294099 P304 "212-218" @default.
- Q83294099 P31 Q13442814 @default.
- Q83294099 P356 "10.1016/J.YGYNO.2006.02.026" @default.
- Q83294099 P433 "1" @default.
- Q83294099 P478 "103" @default.
- Q83294099 P577 "2006-05-03T00:00:00Z" @default.
- Q83294099 P698 "16677696" @default.
- Q83294099 P921 Q18936 @default.